Blog

Home » Blog

VIDEO: Dr. Patrick Lee PhD, “Using viruses to target Prostate Cancer.”

Videos, Awareness Nights, Using Viruses / By / / 1 minute of reading

    Dr. Patrick Lee, PhD Professor Department of Microbiology & Immunology Faculty of Medicine Dalhousie University, Halifax, NS, Canada Dr. Lee’s approach to the treatment of prostate cancer is evolutionary, forward-looking, and revolutionary: a focus on the reovirus, a naturally-occuring benign human virus. The reovirus is used directly to infect cancer cells and indirectly to activate the body’s immune system against cancer cells. Dr. Lee’s presentation at the October 2011 PCC Conference in Halifax was a definite highlight and we are thrilled that he was our special Prostate Cancer Week Awareness Night speaker. CLICK ON THE ARROW TO START […]

VIDEO: Dr. Patrick Lee PhD, “Using viruses to target Prostate Cancer.” Read More »

UI Surgery Rates Rise Years After RP: An Interview with Robert K. Nam, MD, MSc

Incontinence, Radical Prostatectomy / By / / 1 minute of reading

Long-term quality of life for men who have undergone radical prostatectomy (RP) is inextricably tied to urinary incontinence (UI) issues. Robert K. Nam, MD, MSc, and colleagues helped to shed light on the impact of this side effect by studying rates of UI-corrective surgery occurring up to 15 years following radical prostatectomy. Read More.

UI Surgery Rates Rise Years After RP: An Interview with Robert K. Nam, MD, MSc Read More »

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter September 2012

Newsletters / By / / 1 minute of reading

In this Issue We welcome Dr. Patrick Lee Clinic celebrates 5 years Two new clinics opening Dr. Patrick Lee North York Harvest Food Bank Thank you to Scotiabank Pictures of our Walk/Run Meet Denis Farbstein PCCN Regina conference Dr. Uri Lindner 2nd annual AIM meeting Pictures from volunteers dinner On-going Projects for 2012 PCCN-Toronto Board of Directors Read it by clicking the link below to open the pdf file: Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter September 2012 (pdf)

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter September 2012 Read More »

Breast cancer drug may ease prostate cancer side effects

Advanced Prostate Cancer, Hormone Side Effects / By / / 1 minute of reading

A widely used breast cancer drug may ease the side effects of prostate cancer treatment, according to a new German study. Scientists examined four studies involving men in Europe and North America undergoing therapy for prostate cancer, the common side effects of which are gynecomastia (breast enlargement) or breast pain. Read More.

Breast cancer drug may ease prostate cancer side effects Read More »

Survival Better with Continuous ADT

Advanced Prostate Cancer / By / / 1 minute of reading

Intermittent androgen deprivation therapy (ADT) has some quality-of-life (QOL) benefits for men with metastatic prostate cancer, but overall survival times are inferior to those seen with continuous ADT, according to the findings of a 17-year study (SWOG9346) presented at the American Society for Clinical Oncology 2012 annual meeting. Read More.

Survival Better with Continuous ADT Read More »

Drug from Mediterranean weed kills tumor cells in mice

Chemotherapy / By / / 1 minute of reading

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal cells through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a “molecular grenade,” and sparing healthy blood vessels and tissues. Read More.

Drug from Mediterranean weed kills tumor cells in mice Read More »

Questioning Surgery for Early Prostate Cancer

Active Surveillance, Radical Prostatectomy / By / / 1 minute of reading

A new study shows that prostate cancer surgery, which often leaves men impotent or incontinent, does not appear to save the lives of men with early-stage disease, who account for most cases, and many of these men would do just as well to choose no treatment at all. From the NY Times And a second article  

Questioning Surgery for Early Prostate Cancer Read More »

Scroll to Top